Most Popular in:
Source of Innovation: The Story of Ingredients
By: Sara Mason
Posted: July 31, 2014, from the August 2014 issue of Skin Inc. magazine.
page 7 of 8
Often, the process itself is the major reason Sabinsa is able to obtain that ingredient. In such cases, where the ingredient itself may or may not be novel, the process taken to get there is, and certainly can be worthwhile protecting. The novelty, not the monopoly, of such unique processes and innovative ingredients helps reduce the number of generic or counterfeit products that enter the industry, which ultimately affects consumer confidence with regard to the types of ingredients or formulas being offered. The processes Sabinsa embarks on for patenting have been scientifically validated through high levels of scrutiny. “We want to ensure it’s not only the best way to obtain such a product, but the safest way,” Majeed says. “Another reason to patent unique processes might be to protect how well we’ve optimized the yield in which we obtain the final product.”
One of Sabinsa’s most recent patents is for Boswellin from the dry, hilly parts of India. The European patent discusses the unique therapeutic potential of boswellic acids from the gum resin in combination with selenium amino acids to effectively manage inflammatory conditions of immunological origin, such as psoriasis.
Ensuring that patents are protected also allows forerunners to continue to invest in innovation. “Innovation is a major driving force in almost every industry,” says Majeed. “For much of it, changing government policies, shifting demographics and economic pressures often create a necessity for innovation.”
Sara Mason is a freelance writer based in the Chicagoland area. She was previously managing editor of GCI magazine.